Print page content Print
Increase text size Decrease text size
Text Size

This site is intended for U.S. animal healthcare professionals

Cytopoint

This site is intended for U.S. animal healthcare professionals

Charlie and Molly

Individualized care starts with identifying dogs in need of lasting relief from allergic itch

CYTOPOINT® has been shown to be effective for the treatment of dogs against allergic dermatitis and atopic dermatitis

CYTOPOINT is a great choice for:

  • dogs who are difficult to pill or cases in which owner compliance with pilling is a concern
  • dogs with comorbidities and taking other medications
  • owners who seek non-drug therapy
  • dogs of all ages, including those under 12 months of age
  • dogs requiring lasting, life-long disease management

CYTOPOINT is a ready-to-use injection containing a caninized monoclonal antibody

How to dose CYTOPOINT for treatment success

  • CYTOPOINT is available in single-use 1-mL vials in 4 concentrations: 10, 20, 30 or 40 mg/vial
  • CYTOPOINT injection is administered at a minimum dose of 0.9 mg/lb body weight
  • CYTOPOINT is drawn at full volume from each vial (as indicated by the dosing chart below) into 1 syringe and administered subcutaneously as a single injection

CYTOPOINT dosing chart

dosing chart mobiledosing chart desktop

Dosing instructions per U.S. product label. The dose varies depending on country of licensure.

Progress exams with CYTOPOINT therapy help determine when dogs have achieved treatment success

How to store CYTOPOINT

  • Store vials upright, in original packaging, at 2°-8°C/36°-47°F. Do not freeze
    • Prolonged exposure to higher temperature and/or direct sunlight may adversely affect potency
  • CYTOPOINT contains no preservatives and vials are single-use only
  • Vials should be discarded after puncture. Do not split vials between patients
Vials mobile Vials desktop

Prepare for possible flares with long-term allergic itch treatment

  • Set expectations for possible flares of itch with the pet owner, and maintain open, two-way communication during treatment
  • If the pet owner suspects a flare, avoid over-the-phone treatment recommendations and schedule an exam for the dog
  • Complete an exam to identify the underlying cause of the flare (eg, fleas, dietary indiscretion, infection, seasonal allergy)
  • Advise the pet owner to continue CYTOPOINT treatment during the flare
  • Provide additional, short-term anti-pruritic relief as needed, such as APOQUEL® (oclacitinib tablet)
Prepare for flares with long-term allergic itch treatment

Indications: CYTOPOINT has been shown to be effective for the treatment of dogs against allergic dermatitis and atopic dermatitis.

APOQUEL Indications: Control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.

APOQUEL Important Safety Information: Do not use APOQUEL in dogs less than 12 months of age or those with serious infections. APOQUEL may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or pre-existing cancers to get worse. APOQUEL has not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporine. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. APOQUEL has been used safely with many common medications including parasiticides, antibiotics and vaccines.

For more information, please see the full Prescribing Information.

References: 1. Data on file, Study Report No. C863R-US-12-018, 2014, Zoetis Inc.

This site is intended for U.S. Animal Healthcare Professionals. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. 

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.
© 2020 Zoetis Services LLC. All rights reserved. CYT-00090R5

CONTACT US

1-888-963-8471

We are Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2020 Zoetis Services LLC. All rights reserved.